BRL 16.8
(-5.46%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 2.19 Billion BRL | -0.19% |
2022 | 2.19 Billion BRL | 68.47% |
2021 | 1.3 Billion BRL | 41.56% |
2020 | 920.79 Million BRL | 38.54% |
2019 | 664.64 Million BRL | 11.39% |
2018 | 596.68 Million BRL | 31.2% |
2017 | 454.77 Million BRL | 5.44% |
2016 | 431.31 Million BRL | 16.67% |
2015 | 369.67 Million BRL | -44.13% |
2014 | 661.66 Million BRL | 11.91% |
2013 | 591.27 Million BRL | 34.75% |
2012 | 438.77 Million BRL | -18.85% |
2011 | 540.68 Million BRL | 16.1% |
2010 | 465.69 Million BRL | 45.76% |
2009 | 319.49 Million BRL | 52.04% |
2008 | 210.13 Million BRL | 77.51% |
2007 | 118.37 Million BRL | 114.83% |
2006 | 55.1 Million BRL | 445.54% |
2005 | 10.1 Million BRL | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 1.93 Billion BRL | -7.86% |
2024 Q1 | 2.09 Billion BRL | -4.39% |
2023 Q3 | 2.2 Billion BRL | -4.13% |
2023 FY | 2.19 Billion BRL | -0.19% |
2023 Q2 | 2.3 Billion BRL | -3.85% |
2023 Q1 | 2.39 Billion BRL | 9.04% |
2023 Q4 | 2.19 Billion BRL | -0.7% |
2022 FY | 2.19 Billion BRL | 68.47% |
2022 Q1 | 1.53 Billion BRL | 17.46% |
2022 Q3 | 2 Billion BRL | 18.1% |
2022 Q2 | 1.7 Billion BRL | 11.12% |
2022 Q4 | 2.19 Billion BRL | 9.29% |
2021 Q2 | 1.15 Billion BRL | 4.9% |
2021 Q3 | 1.23 Billion BRL | 6.69% |
2021 Q4 | 1.3 Billion BRL | 5.94% |
2021 FY | 1.3 Billion BRL | 41.56% |
2021 Q1 | 1.09 Billion BRL | 19.39% |
2020 FY | 920.79 Million BRL | 38.54% |
2020 Q4 | 920.79 Million BRL | 3.26% |
2020 Q1 | 697.11 Million BRL | 4.89% |
2020 Q2 | 802.39 Million BRL | 15.1% |
2020 Q3 | 891.74 Million BRL | 11.14% |
2019 Q2 | 655.32 Million BRL | -1.32% |
2019 Q1 | 664.06 Million BRL | 11.29% |
2019 FY | 664.64 Million BRL | 11.39% |
2019 Q4 | 664.64 Million BRL | -0.33% |
2019 Q3 | 666.86 Million BRL | 1.76% |
2018 FY | 596.68 Million BRL | 31.2% |
2018 Q4 | 596.68 Million BRL | 4.75% |
2018 Q3 | 569.61 Million BRL | 7.66% |
2018 Q2 | 529.09 Million BRL | 5.59% |
2018 Q1 | 501.08 Million BRL | 10.18% |
2017 Q4 | 454.77 Million BRL | 30.12% |
2017 Q3 | 349.5 Million BRL | 2.75% |
2017 Q2 | 340.13 Million BRL | 2.1% |
2017 Q1 | 333.15 Million BRL | -22.76% |
2017 FY | 454.77 Million BRL | 5.44% |
2016 Q3 | 396.6 Million BRL | 1.56% |
2016 FY | 379.99 Million BRL | 16.67% |
2016 Q4 | 431.31 Million BRL | 8.75% |
2016 Q2 | 390.52 Million BRL | 8.93% |
2016 Q1 | 358.51 Million BRL | -3.02% |
2015 Q2 | 827.37 Million BRL | 11.32% |
2015 FY | 369.67 Million BRL | -44.13% |
2015 Q4 | 369.67 Million BRL | -60.72% |
2015 Q3 | 941.11 Million BRL | 13.75% |
2015 Q1 | 743.23 Million BRL | 12.33% |
2014 Q4 | 661.66 Million BRL | -0.33% |
2014 Q3 | 663.82 Million BRL | 17.85% |
2014 Q2 | 563.26 Million BRL | -2.4% |
2014 FY | 661.66 Million BRL | 11.91% |
2014 Q1 | 577.09 Million BRL | -2.4% |
2013 Q1 | 553.23 Million BRL | 26.08% |
2013 Q2 | 626.14 Million BRL | 13.18% |
2013 Q3 | 626.67 Million BRL | 0.08% |
2013 Q4 | 591.27 Million BRL | -5.65% |
2013 FY | 591.27 Million BRL | 34.75% |
2012 Q4 | 438.77 Million BRL | -4.39% |
2012 Q1 | 508.71 Million BRL | -5.91% |
2012 Q2 | 512.81 Million BRL | 0.81% |
2012 Q3 | 458.93 Million BRL | -10.51% |
2012 FY | 438.77 Million BRL | -18.85% |
2011 Q1 | 685.01 Million BRL | 47.09% |
2011 Q3 | 660.35 Million BRL | -11.77% |
2011 Q2 | 748.47 Million BRL | 9.27% |
2011 Q4 | 540.68 Million BRL | -18.12% |
2011 FY | 540.68 Million BRL | 16.1% |
2010 Q3 | 490.57 Million BRL | 49.12% |
2010 FY | 465.69 Million BRL | 45.76% |
2010 Q2 | 328.97 Million BRL | 1.53% |
2010 Q4 | 465.69 Million BRL | -5.07% |
2010 Q1 | 324 Million BRL | 1.41% |
2009 Q4 | 319.49 Million BRL | 0.0% |
2009 FY | 319.49 Million BRL | 52.04% |
2008 FY | 210.13 Million BRL | 77.51% |
2007 FY | 118.37 Million BRL | 114.83% |
2006 FY | 55.1 Million BRL | 445.54% |
2005 FY | 10.1 Million BRL | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Blau FarmacĂȘutica S.A. | 628.64 Million BRL | -248.643% |